hydroxychloroquine has been researched along with Meigs Syndrome in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Meigs Syndrome: The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horino, T | 1 |
| Ogasawara, M | 1 |
| Kashio, T | 1 |
| Inotani, S | 1 |
| Ishihara, M | 1 |
| Ohnishi, H | 1 |
| Komori, M | 1 |
| Ichii, O | 1 |
| Terada, Y | 1 |
| Ural, UM | 1 |
| Kiliç, A | 1 |
| Güngör, T | 1 |
| Ozdal, B | 1 |
| Mollamahmutoğlu, L | 1 |
2 other studies available for hydroxychloroquine and Meigs Syndrome
| Article | Year |
|---|---|
Lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs' syndrome and successfully treated with hydroxychloroquine.
Topics: Ascites; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Meigs Syndrome; Protein- | 2022 |
Tjalma's or pseudo-pseudo-Meigs' syndrome: a case report.
Topics: Adult; Ascites; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Human | 2008 |